# Development of Diagnostic Pathway for Teicoplanin Allergy

> **NCT03210233** · NA · UNKNOWN · sponsor: **The Leeds Teaching Hospitals NHS Trust** · enrollment: 548 (estimated)

## Conditions studied

- Hypersensitivity

## Interventions

- **PROCEDURE:** Blood test, skin testing and challenge testing.

## Key facts

- **NCT ID:** NCT03210233
- **Lead sponsor:** The Leeds Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 548 (ESTIMATED)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03210233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03210233, "Development of Diagnostic Pathway for Teicoplanin Allergy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03210233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*